Sumoylation induced by the Arf tumor suppressor

A p53-independent function

Kenji Tago, Susanna Chiocca, Charles J. Sherr

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

The mouse p19 Arf protein has both p53-dependent and p53-independent tumor-suppressive activities. Arf triggers sumoylation of many cellular proteins, including Mdm2 and nucleophosmin (NPM/ B23), with which p19 Arf physically interacts in vivo, and this occurs equally well in cells expressing or lacking functional p53. In an Arf-null NIH 3T3 cell derivative (MT-Arf cells) engineered to reexpress an Arf transgene driven by a zinc-inducible metallothionein promoter, sumoylation of endogenous Mdm2 and NPM proteins was initiated as p19 Arf was induced and was observed before p53-dependent cell cycle arrest. Predominately nucleoplasmic molecules visualized by immunofluorescence with antibodies to small ubiquitin-like modifier (SUMO) 1 localized to nucleoli as p19 Arf accumulated there. Two Arf mutants, one of which binds to Mdm2 and NPM but is excluded from nucleoli and the other of which enters nucleoli but is handicapped in binding to Mdm2 and NPM, were defective in inducing sumoylation of these two target proteins and did not localize bulk sumoylated molecules to nucleoli. The CELO adenovirus protein, Gam1, which inhibits the SUMO activating enzyme (E1) and leads to down-regulation of the SUMO conjugating enzyme (E2/Ubc9), had no overt effect on the ability of p19 Arf to activate p53 or the p53-responsive genes encoding Mdm2 and p21 cip1, despite the fact that Arf-induced sumoylation of Mdm2 was blocked. Reduction of Ubc9 levels with short hairpin RNAs rendered similar results. We suggest that Arf's p53-independent effects on gene expression and tumor suppression might depend on Arf-induced sumoylation.

Original languageEnglish
Pages (from-to)7689-7694
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume102
Issue number21
DOIs
Publication statusPublished - May 24 2005

Fingerprint

Sumoylation
Proto-Oncogene Proteins c-mdm2
Ubiquitin
Neoplasms
NIH 3T3 Cells
p53 Genes
Enzymes
Cell Cycle Checkpoints
Transgenes
Small Interfering RNA
Fluorescent Antibody Technique
Down-Regulation
Gene Expression
Antibodies
Proteins

Keywords

  • Gam1
  • Ubc9

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Sumoylation induced by the Arf tumor suppressor : A p53-independent function. / Tago, Kenji; Chiocca, Susanna; Sherr, Charles J.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 21, 24.05.2005, p. 7689-7694.

Research output: Contribution to journalArticle

@article{85d0338fe73b4bf7b330ab51fb95252c,
title = "Sumoylation induced by the Arf tumor suppressor: A p53-independent function",
abstract = "The mouse p19 Arf protein has both p53-dependent and p53-independent tumor-suppressive activities. Arf triggers sumoylation of many cellular proteins, including Mdm2 and nucleophosmin (NPM/ B23), with which p19 Arf physically interacts in vivo, and this occurs equally well in cells expressing or lacking functional p53. In an Arf-null NIH 3T3 cell derivative (MT-Arf cells) engineered to reexpress an Arf transgene driven by a zinc-inducible metallothionein promoter, sumoylation of endogenous Mdm2 and NPM proteins was initiated as p19 Arf was induced and was observed before p53-dependent cell cycle arrest. Predominately nucleoplasmic molecules visualized by immunofluorescence with antibodies to small ubiquitin-like modifier (SUMO) 1 localized to nucleoli as p19 Arf accumulated there. Two Arf mutants, one of which binds to Mdm2 and NPM but is excluded from nucleoli and the other of which enters nucleoli but is handicapped in binding to Mdm2 and NPM, were defective in inducing sumoylation of these two target proteins and did not localize bulk sumoylated molecules to nucleoli. The CELO adenovirus protein, Gam1, which inhibits the SUMO activating enzyme (E1) and leads to down-regulation of the SUMO conjugating enzyme (E2/Ubc9), had no overt effect on the ability of p19 Arf to activate p53 or the p53-responsive genes encoding Mdm2 and p21 cip1, despite the fact that Arf-induced sumoylation of Mdm2 was blocked. Reduction of Ubc9 levels with short hairpin RNAs rendered similar results. We suggest that Arf's p53-independent effects on gene expression and tumor suppression might depend on Arf-induced sumoylation.",
keywords = "Gam1, Ubc9",
author = "Kenji Tago and Susanna Chiocca and Sherr, {Charles J.}",
year = "2005",
month = "5",
day = "24",
doi = "10.1073/pnas.0502978102",
language = "English",
volume = "102",
pages = "7689--7694",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "21",

}

TY - JOUR

T1 - Sumoylation induced by the Arf tumor suppressor

T2 - A p53-independent function

AU - Tago, Kenji

AU - Chiocca, Susanna

AU - Sherr, Charles J.

PY - 2005/5/24

Y1 - 2005/5/24

N2 - The mouse p19 Arf protein has both p53-dependent and p53-independent tumor-suppressive activities. Arf triggers sumoylation of many cellular proteins, including Mdm2 and nucleophosmin (NPM/ B23), with which p19 Arf physically interacts in vivo, and this occurs equally well in cells expressing or lacking functional p53. In an Arf-null NIH 3T3 cell derivative (MT-Arf cells) engineered to reexpress an Arf transgene driven by a zinc-inducible metallothionein promoter, sumoylation of endogenous Mdm2 and NPM proteins was initiated as p19 Arf was induced and was observed before p53-dependent cell cycle arrest. Predominately nucleoplasmic molecules visualized by immunofluorescence with antibodies to small ubiquitin-like modifier (SUMO) 1 localized to nucleoli as p19 Arf accumulated there. Two Arf mutants, one of which binds to Mdm2 and NPM but is excluded from nucleoli and the other of which enters nucleoli but is handicapped in binding to Mdm2 and NPM, were defective in inducing sumoylation of these two target proteins and did not localize bulk sumoylated molecules to nucleoli. The CELO adenovirus protein, Gam1, which inhibits the SUMO activating enzyme (E1) and leads to down-regulation of the SUMO conjugating enzyme (E2/Ubc9), had no overt effect on the ability of p19 Arf to activate p53 or the p53-responsive genes encoding Mdm2 and p21 cip1, despite the fact that Arf-induced sumoylation of Mdm2 was blocked. Reduction of Ubc9 levels with short hairpin RNAs rendered similar results. We suggest that Arf's p53-independent effects on gene expression and tumor suppression might depend on Arf-induced sumoylation.

AB - The mouse p19 Arf protein has both p53-dependent and p53-independent tumor-suppressive activities. Arf triggers sumoylation of many cellular proteins, including Mdm2 and nucleophosmin (NPM/ B23), with which p19 Arf physically interacts in vivo, and this occurs equally well in cells expressing or lacking functional p53. In an Arf-null NIH 3T3 cell derivative (MT-Arf cells) engineered to reexpress an Arf transgene driven by a zinc-inducible metallothionein promoter, sumoylation of endogenous Mdm2 and NPM proteins was initiated as p19 Arf was induced and was observed before p53-dependent cell cycle arrest. Predominately nucleoplasmic molecules visualized by immunofluorescence with antibodies to small ubiquitin-like modifier (SUMO) 1 localized to nucleoli as p19 Arf accumulated there. Two Arf mutants, one of which binds to Mdm2 and NPM but is excluded from nucleoli and the other of which enters nucleoli but is handicapped in binding to Mdm2 and NPM, were defective in inducing sumoylation of these two target proteins and did not localize bulk sumoylated molecules to nucleoli. The CELO adenovirus protein, Gam1, which inhibits the SUMO activating enzyme (E1) and leads to down-regulation of the SUMO conjugating enzyme (E2/Ubc9), had no overt effect on the ability of p19 Arf to activate p53 or the p53-responsive genes encoding Mdm2 and p21 cip1, despite the fact that Arf-induced sumoylation of Mdm2 was blocked. Reduction of Ubc9 levels with short hairpin RNAs rendered similar results. We suggest that Arf's p53-independent effects on gene expression and tumor suppression might depend on Arf-induced sumoylation.

KW - Gam1

KW - Ubc9

UR - http://www.scopus.com/inward/record.url?scp=19644384513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19644384513&partnerID=8YFLogxK

U2 - 10.1073/pnas.0502978102

DO - 10.1073/pnas.0502978102

M3 - Article

VL - 102

SP - 7689

EP - 7694

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 21

ER -